Clinical trialNCT03078933UnknownInterventional

A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers

SponsorOrigin Inc.Enrollment100Diabetic Foot Ulcer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The clinical trial will assess the delivery of Nitric Oxide topically to the diabetic foot ulcer wound and the surrounding wound area as it related to wound healing. The objective of the study is to assess the Nitric Oxide Therapy treatment time (the number of minutes to deliver the treatment) and frequency (number of days per week to treat) to determine the most optimal treatment time and frequency to develop a rationale for safety and efficacy for the final APT001 clinical study.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

David Dantzker, MD
Origin Inc.
Study Chair
clinicaltrials.gov ↗
Terry Treadwell, MD
Institute for Advanced Wound Care
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Clinical Site
Montgomery, Alabama, United States
Recruiting
Clinical Site
Phoenix, Arizona, United States
Recruiting
Clinical Site
Tucson, Arizona, United States
Recruiting
Clinical Site
Fresno, California, United States
Recruiting
Clinical Site
Los Angeles, California, United States
Recruiting
Clinical Site
San Francisco, California, United States
Recruiting
Clinical Site
Sylmar, California, United States
Recruiting
Clinical Site
Cooper City, Florida, United States
Recruiting
Clinical Site
Miami, Florida, United States
Recruiting
Clinical Site
Miami, Florida, United States
Recruiting
Clinical Site
Boston, Massachusetts, United States
Recruiting
Clinical Site
West Columbia, South Carolina, United States
Recruiting
Clinical Site
Corpus Christi, Texas, United States
Recruiting
Clinical Site
San Antonio, Texas, United States
Recruiting
Clinical Site
Webster, Texas, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 20 Mar 2017
Primary completion: 31 May 2018
Completion: 31 Jul 2018
Last update posted: 7 Jun 2017
Registered enrollment: 100
Registry id: NCT03078933

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.